The clinical use of Sugmadex eliminate many of the shortcomings in current anaesthetic practice. Sugmadex is available as 2 ml & 5 ml single-dose vials
BDR Pharmaceuticals and Varenyam Healthcare announce the launch of Sugmadex – an innovative drug with novel γ-cyclodextrin neuromuscular block (NMB) reversal properties.
Sugmadex (Sugammadex 100mg/ml) is anaesthesia drug which provides safe, rapid and complete reversal of shallow, moderate and deep neuromuscular block (NMB), resulting in the removal of anaesthesia effect on the body.
Currently available reversal agents cannot reverse profound NMB & quite often result in postoperative respiratory complications.
The clinical use of Sugmadex eliminate many of the shortcomings in current anaesthetic practice. Sugmadex is available as 2 ml & 5 ml single-dose vials.
Sugmadex is going to be more efficient, effective and life-saving for patients with severe complications thereby improving overall rate of recovery.